DIANT Pharma

company

About

DIANT Pharma develops continuous processing technology for nanoparticle drug products and vaccines.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$256K
Industries
Biopharma,Biotechnology,Nanotechnology
Founded date
Jan 1, 2019
Number Of Employee
11 - 50
Operating Status
Active

DIANT Pharma develops continuous processing technology for nanoparticle drug products and vaccines. They utilize a proprietary and continuous ethanol-injection system to form nanoparticles with controlled particle sizes at high flow rates, providing pharmaceutical companies with a continuous drug encapsulation technique to achieve their goals and high encapsulation processes.

Founded in 2019, DIANT offers technology that is robust and reliable from R&D to manufacturing over a product’s lifespan.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$256K
DIANT Pharma has raised a total of $256K in funding over 2 rounds. Their latest funding was raised on Feb 9, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 9, 2022 Grant $256K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
1
1
DIANT Pharma is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant